GGrantIndex
Sort

53,477 grants matching addiction

Dissecting the Abuse Liability of Synthetic Cathinone Stimulants

$433,125
Michael A Taffe · Scripps Research Institute, The · R01 · FY2016 · DA

Relapse-suppressing brain mechanisms in alcoholism: role of the mPFC

$433,125
Nobuyoshi Suto · Scripps Research Institute, The · R01 · FY2019 · AA

Dissecting the Abuse Liability of Synthetic Cathinone Stimulants

$433,125
Michael A Taffe · Scripps Research Institute, The · R01 · FY2017 · DA

Relapse-suppressing brain mechanisms in alcoholism: role of the mPFC

$433,125
Nobuyoshi Suto · Scripps Research Institute, The · R01 · FY2018 · AA

Proteoglycan Signaling as a New Therapeutic Target for Cocaine Addiction

$433,125
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2017 · DA

Discovery and therapeutic targeting of biological determinants of lung cancer health disparities

$433,114
Sharon R. Pine · University Of Colorado Denver · R01 · FY2025 · CA

Endocannabinoids and the Control Of Behavior and Cardiovascular Function

$433,090
George Kunos · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA

Spatiotemporal Brain Imaging of Alcohol Effects on Inhibitory Control

$433,052
Ksenija Marinkovic · San Diego State University · R01 · FY2014 · AA

GDNF gene therapy to block relapse of heavy alcohol use in monkeys

$433,009
Matthew M Ford · Oregon Health & Science University · R01 · FY2018 · AA

Morphine, HIV proteins, wound healing and Infection

$433,003
Sabita Roy · University Of Minnesota · R01 · FY2010 · DA

Inflammatory and Dysregulated Repair Responses to Inhaled Nicotine

$432,989
Irfan Rahman · University Of Rochester · R01 · FY2021 · HL

Variants in CHRNA5/CHRNA3/CHRNB4 and nicotine dependence

$432,963
Xiangning Chen · Virginia Commonwealth University · R21 · FY2009 · DA

Behavioral and neural mechanisms mediating social motivation in a rat model for ASD

$432,962
Marco Venniro · University Of Maryland Baltimore · R01 · FY2023 · MH

Development of inhibitors targeting Plk1 polo-box domain

$432,961
Kyung W Lee · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Evaluation of Family Behavior Therapy for Substance Abuse in Collegiate Athletes

$432,956
Bradley C Donohue · University Of Nevada Las Vegas · R01 · FY2014 · DA

The role of ENDS use in changing rates of escalation and quitting of cigarette smoking in those under age 35 years in US population

$432,923
John P Pierce · University Of California, San Diego · R01 · FY2019 · CA

Opioid modulation of the coeruleo-cortical pathway

$432,904
Elisabeth J Van Bockstaele · Drexel University · R01 · FY2016 · DA

Brain Biomarkers of Alcoholism and Abstinence

$432,888
Howard B Gutstein · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · AA

Cerebellum and Addiction

$432,846
Kamran Khodakhah · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · DA

AA12404 Gene expression in the human alcoholic brain

$432,837
University Of Texas Austin · R01 · FY2005 · AA

Cannabinoid and terpene regulation of nocioception and peripheral sensitization through ionotropic receptors

$432,795
Helen C Turner · Chaminade University Of Honolulu · R15 · FY2020 · DA

Smoking Cessation Among Methadone Maintained Patients

$432,789
Rhode Island Hospital (Providence, Ri) · R01 · FY2002 · CA

Functions of distinct orbitofrontal cell-types and pathways in decision making

$432,772
Adam Kepecs · Cold Spring Harbor Laboratory · R01 · FY2019 · DA

Maternal Opioid Treatment: Human Experimental Research

$432,768
Women And Infants Hospital-Rhode Island · R01 · FY2004 · DA

Development of Orexin-1 Receptor Antagonists to Prevent Drug Relapse

$432,750
Paul J Kenny · Scripps Research Institute, The · R01 · FY2007 · DA